Search

everythinglearnresearchcommunity

for

Search:↓

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The drug combination was safe and showed promise in treating advanced tumors.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Enhancing Tregs can protect against alopecia areata.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Tofacitinib effectively treats Alopecia Areata.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Rituximab may cause skin issues, but baricitinib can help improve them.